# Bioventus Inc.: filings

BVS · Nasdaq · CIK 1665988 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bvs.md) · [Financials](/companies/bvs/financials.md) · [Filings](/companies/bvs/filings.md) · [Insiders](/companies/bvs/insiders.md)

## Reports and events: 112 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 218, 8-K 70, 3 26, 10-Q 17, 144 14, S-8 10, SC 13G/A 7, 10-K 6, CORRESP 6, DEFA14A 6, 425 5, 4/A 5, DEF 14A 5, S-1/A 5, SC 13G 5, UPLOAD 5, 8-K/A 3, ARS 3, EFFECT 3, SC 13D/A 3, SCHEDULE 13G/A 3, SEC STAFF LETTER 3, 424B3 2, 8-A12B 2, CERTNAS 2, DRS 2, DRS/A 2, DRSLTR 2, NT 10-Q 2, S-1 2, SD 2, 3/A 1, 424B4 1, CERT 1, NT 10-K 1, PRE 14A 1, RW 1, S-1MEF 1, S-3 1, S-4 1, S-4/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 07:43 ET | [10-Q](/filings/0001665988-26-000042.md) | Quarterly report, period 2026-06-27 | 0001665988-26-000042 |
| 2026-08-05 | 07:40 ET | [8-K](/filings/0001665988-26-000041.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001665988-26-000041 |
| 2026-06-04 | 07:54 ET | [8-K](/filings/0001665988-26-000035.md) | 5.07 Shareholder vote results | 0001665988-26-000035 |
| 2026-05-21 | 16:58 ET | [8-K](/filings/0001665988-26-000029.md) | 7.01 Regulation FD disclosure | 0001665988-26-000029 |
| 2026-05-06 | 07:48 ET | [10-Q](/filings/0001665988-26-000027.md) | Quarterly report, period 2026-03-28 | 0001665988-26-000027 |
| 2026-05-06 | 07:46 ET | [8-K](/filings/0001665988-26-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-26-000026 |
| 2026-04-22 | 07:51 ET | [DEF 14A](/filings/0001665988-26-000014.md) | Proxy statement, period 2025-12-31 | 0001665988-26-000014 |
| 2026-03-05 | 07:37 ET | [10-K](/filings/0001665988-26-000011.md) | Annual report, period 2025-12-31 | 0001665988-26-000011 |
| 2026-03-05 | 07:34 ET | [8-K](/filings/0001665988-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-26-000010 |
| 2025-11-17 | 17:04 ET | [8-K](/filings/0001665988-25-000032.md) | 5.02 Departure or appointment of officers or directors | 0001665988-25-000032 |
| 2025-11-04 | 07:39 ET | [10-Q](/filings/0001665988-25-000026.md) | Quarterly report, period 2025-09-27 | 0001665988-25-000026 |
| 2025-11-04 | 07:37 ET | [8-K](/filings/0001665988-25-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-25-000025 |
| 2025-08-06 | 07:45 ET | [10-Q](/filings/0001665988-25-000017.md) | Quarterly report, period 2025-06-28 | 0001665988-25-000017 |
| 2025-08-06 | 07:42 ET | [8-K](/filings/0001665988-25-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-25-000016 |
| 2025-08-04 | 08:15 ET | [8-K](/filings/0001193125-25-172192.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-172192 |
| 2025-07-31 | 08:12 ET | [8-K](/filings/0001665988-25-000013.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001665988-25-000013 |
| 2025-06-04 | 16:16 ET | [8-K](/filings/0001665988-25-000010.md) | 5.07 Shareholder vote results | 0001665988-25-000010 |
| 2025-05-06 | 07:38 ET | [10-Q](/filings/0001628280-25-022401.md) | Quarterly report, period 2025-03-29 | 0001628280-25-022401 |
| 2025-05-06 | 07:36 ET | [8-K](/filings/0001628280-25-022400.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022400 |
| 2025-04-22 | 08:10 ET | [DEF 14A](/filings/0001628280-25-018715.md) | Proxy statement, period 2024-12-31 | 0001628280-25-018715 |
| 2025-03-11 | 07:42 ET | [10-K](/filings/0001628280-25-011831.md) | Annual report, period 2024-12-31 | 0001628280-25-011831 |
| 2025-03-11 | 07:40 ET | [8-K](/filings/0001628280-25-011830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-011830 |
| 2025-01-03 | 16:09 ET | [8-K](/filings/0001628280-25-000253.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-000253 |
| 2024-11-05 | 07:36 ET | [10-Q](/filings/0001628280-24-045114.md) | Quarterly report, period 2024-09-28 | 0001628280-24-045114 |
| 2024-11-05 | 07:34 ET | [8-K](/filings/0001628280-24-045112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045112 |
| 2024-10-04 | 07:45 ET | [8-K](/filings/0001628280-24-042266.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042266 |
| 2024-08-06 | 07:51 ET | [10-Q](/filings/0001628280-24-034979.md) | Quarterly report, period 2024-06-29 | 0001628280-24-034979 |
| 2024-08-06 | 07:40 ET | [8-K](/filings/0001628280-24-034976.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034976 |
| 2024-07-19 | 16:16 ET | [8-K](/filings/0001193125-24-181655.md) | 8.01 Other events | 0001193125-24-181655 |
| 2024-06-21 | 16:30 ET | [8-K](/filings/0001193125-24-165735.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-165735 |
| 2024-06-17 | 16:53 ET | [8-K](/filings/0001193125-24-162669.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-162669 |
| 2024-05-07 | 07:36 ET | [10-Q](/filings/0001628280-24-020846.md) | Quarterly report, period 2024-03-30 | 0001628280-24-020846 |
| 2024-05-07 | 07:33 ET | [8-K](/filings/0001628280-24-020843.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020843 |
| 2024-04-26 | 07:38 ET | [DEF 14A](/filings/0001628280-24-018431.md) | Proxy statement, period 2024-06-11 | 0001628280-24-018431 |
| 2024-03-12 | 07:51 ET | [10-K](/filings/0001628280-24-010376.md) | Annual report, period 2023-12-31 | 0001628280-24-010376 |
| 2024-03-12 | 07:45 ET | [8-K](/filings/0001628280-24-010371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-010371 |
| 2024-01-19 | 08:27 ET | [8-K](/filings/0001193125-24-010779.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-010779 |
| 2024-01-12 | 17:10 ET | [8-K](/filings/0001193125-24-007640.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-007640 |
| 2023-12-21 | 08:00 ET | [8-K](/filings/0001193125-23-300412.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-300412 |
| 2023-11-07 | 07:40 ET | [10-Q](/filings/0001628280-23-037185.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037185 |
| 2023-11-07 | 07:35 ET | [8-K](/filings/0001628280-23-037183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037183 |
| 2023-08-08 | 08:42 ET | [10-Q](/filings/0001628280-23-027981.md) | Quarterly report, period 2023-07-01 | 0001628280-23-027981 |
| 2023-08-08 | 08:02 ET | [8-K](/filings/0001628280-23-027947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027947 |
| 2023-06-16 | 16:25 ET | [SC 13D/A](/filings/0001214659-23-008582.md) | Ownership report, active investor, amended | 0001214659-23-008582 |
| 2023-06-09 | 17:04 ET | [8-K](/filings/0001628280-23-021758.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-23-021758 |
| 2023-05-26 | 08:39 ET | [8-K](/filings/0001628280-23-019872.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-019872 |
| 2023-05-24 | 16:10 ET | [SC 13D/A](/filings/0001214659-23-007782.md) | Ownership report, active investor, amended | 0001214659-23-007782 |
| 2023-05-16 | 17:12 ET | [10-Q](/filings/0001628280-23-018472.md) | Quarterly report, period 2023-04-01 | 0001628280-23-018472 |
| 2023-05-16 | 16:25 ET | [8-K](/filings/0001628280-23-018425.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-018425 |
| 2023-05-16 | 08:15 ET | [8-K](/filings/0001193125-23-145668.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145668 |

Page 1 of 3. [Older](/companies/bvs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.